This test was included in the oral report of the American Society of Clinical Oncology, which detected tumor recurrence and metastasis earlier than imaging | Tumor | United States

Release time:Apr 14, 2024 02:35 AM

At the 2023 Annual Meeting of the American Society of Clinical Oncology, a research achievement jointly conducted by Shanghai Precision Medical Enterprise Zhiben Medical and Professor Yin Junqiang from the Department of Orthopedics and Oncology at the First Affiliated Hospital of Sun Yat sen University, titled "The Clinical Value of Individualized Customized Small Residual Lesion Detection in Sarcoma", was selected for the oral report of the Clinical Science Seminar, becoming the only Chinese achievement selected for the Clinical Science Seminar. Research has shown that personalized customized MRD testing can predict the recurrence of sarcoma earlier than imaging, and can be used to predict the efficacy of preoperative neoadjuvant therapy.

Sarcoma originates from mesenchymal tissue and often occurs in the skin, subcutaneous tissue, periosteum, and both ends of the long bone. Osteosarcoma is more common in young patients and is more common at both ends of the long bones in the limbs, especially at the lower end of the femur, upper end of the tibia, and upper end of the humerus. Common sarcomas include leiomyoma, lymphosarcoma, synovial sarcoma, etc., all of which belong to malignant tumor lesions.

Professor Yin Junqiang and Zhiben Medical conducted a collaborative study on 84 sarcoma patients through personalized and customized MRD dynamic monitoring. The overall success rate of customizing MRD "test kits" was 78.6%. The research results show that more than half of sarcoma patients have unique tumor mutation genes, and these patients are more suitable for personalized and customized MRD dynamic monitoring. In baseline testing, 100% of circulating tumor DNA can be detected, and postoperative MRD detection results can indicate the recurrence and metastasis of sarcoma earlier than imaging.

Professor Yin Junqiang gave a presentation at the 2023 ASCO Annual Conference.

This study has brought important progress to the dynamic monitoring and efficacy prediction of MRD in sarcoma. In recent years, with the development of precision therapy, MRD detection based on free DNA has become a focus of clinical attention. The so-called free DNA refers to the DNA in the circulating blood that is free outside the cell. This detection method has the characteristics of high sensitivity and specificity, and can sensitively capture the clues in free DNA, thus detecting tumor recurrence earlier than traditional imaging techniques. Therefore, the dynamic monitoring and efficacy prediction of MRD in sarcoma is an excellent prognostic indicator.


This test was included in the oral report of the American Society of Clinical Oncology, which detected tumor recurrence and metastasis earlier than imaging | Tumor | United States

Among the 84 sarcoma patients included in the study, soft tissue sarcoma accounted for 38%, bone tumors accounted for 58%, and 4% were undifferentiated sarcoma. Through whole exome detection, a total of 13577 mutations were detected in these patients, covering 7715 genes, of which 64% were unique to individual patients, indicating heterogeneity in sarcoma patients.

Five patients tested positive for MRD after surgery, indicating recurrence and metastasis earlier than imaging monitoring; The MRD test results of three other patients were consistent with the confirmed recurrence and metastasis on imaging.

At the annual meeting of the American Society of Clinical Oncology, Yin Junqiang also introduced the patient follow-up situation: two patients were found to have pulmonary nodules before surgery, and postoperative MRD dynamic monitoring showed positive results, suspected of pulmonary metastasis. These two patients underwent imaging monitoring in September and October last year, respectively, and the results confirmed that the nodules were enlarged, while the circulating tumor DNA showed an upward trend. These two cases suggest that MRD can assist in predicting the occurrence of metastatic lesions and the progression after treatment.

Based on this, the research team suggests that, on the basis of routine CT follow-up after surgery, more sensitive and frequent MRD detection can be carried out through liquid biopsy peripheral blood MRD detection technology, in order to achieve early warning of recurrence and metastasis, and provide reference for adjusting clinical treatment strategies for patients.

Shanghai International Sister City Youth "Play" Summer Camp Experience Traditional Culture, Make Pankou, Learn Paper Cuttings, Make Dumplings International | Youth | Make Dumplings
Shanghai International Sister City Youth "Play" Summer Camp Experience Traditional Culture, Make Pankou, Learn Paper Cuttings, Make Dumplings International | Youth | Make Dumplings

Making coils, learning Paper Cuttings, making dumplings, walking into the home of summer camp volunteers and feeling the life of Shanghai people... On the 20th, the 2023 Shanghai International Sister City Youth Summer Camp officially opened in Shanghai Shidong Experimental School. 73 campers from 13 cities in 12 countries gathered in Shanghai to open the annual international sister city youth exchange event with their peers in Shanghai. The young partners together carried out activities such as learning excellent traditional Chinese culture courses such as Chinese and traditional Chinese painting, intangible cultural heritage, Chinese clothing, disco, Paper Cuttings, seal cutting, calligraphy, pottery, tea art, Yanzhi, dragon dance, youth forum exchanges in sister cities, investigation of urban cultural landscape, visits to universities and venues, city orientation challenges, and local family life experiences, etc., to bloom their youth. In addition to a rich and colorful summer camp physical activity experience, campers and volunteers

Undergraduate voluntary application starts today! These important reminders and suggestions must be read, @ College Entrance Examination Stage | Undergraduate | Volunteer
Undergraduate voluntary application starts today! These important reminders and suggestions must be read, @ College Entrance Examination Stage | Undergraduate | Volunteer

@All college entrance examination candidates, according to the schedule of the college entrance examination, will fill in their undergraduate preferences for all batches except for the comprehensive evaluation batch from 8:00 a.m. to 8:00 p.m. daily from July 1st to 2nd, and from 8:00 a.m. to 12:00 a.m. on July 3rd. The specific contents of this voluntary application include zero voluntary batch, advance batch, art and sports class A batch, local rural special plan batch, special type enrollment, and ordinary batch. The filling method is as follows: Fresh high school graduates in this city will be arranged uniformly by the high school where they are enrolled; Non local fresh high school graduates will be arranged uniformly by the district recruitment office where they apply. It is important to remind candidates that during the voluntary application period from July 1st to 3rd, as the admission of the comprehensive evaluation batch has not yet been completed, candidates who have filled out the comprehensive evaluation batch of voluntary applications still need to carefully fill out other batches of undergraduate voluntary applications

Investment+Services Drive Anti Cancer Drugs into Clinical Practice | Entrepreneurial Stories in Incubators, Second Entrepreneurial Biology for CEOs of Listed Companies | Incubators | Clinical | Incubators
Investment+Services Drive Anti Cancer Drugs into Clinical Practice | Entrepreneurial Stories in Incubators, Second Entrepreneurial Biology for CEOs of Listed Companies | Incubators | Clinical | Incubators

Recently, with the approval of the National Medical Products Administration, the Class 1 innovative drug CC312 developed by Huihe Biotechnology has initiated phase I clinical trials for the treatment of recurrent/refractory CD19 positive B-cell malignant hematological tumors. This is the first domestically and the third globally approved triple specific antibody drug based on CD28 co stimulatory signals to enter clinical practice. When it comes to the development history of this new triple antibody drug, Dr. Zhu Huaxing, the founder of Huihe Biotechnology, still remembers vividly: "Before 2019, there was no triple antibody drug approved for clinical use globally, and some investors couldn't understand CC312. During a critical period of company development, Nokai Xinkang Fund invested 30 million yuan to help us complete Series A financing." Nokai Xinkang is a venture capital fund initiated by Xinze Entrepreneurship Incubator. This incubation company, which has been deeply cultivated in Zhangjiang Science City for many years

"Zidong Taichu" Full Modal Large Model Released, Precisely Positioned 3D Scene, Listening to "Moonlight Song" and Talking about Beethoven Images | Applications | Beethoven
"Zidong Taichu" Full Modal Large Model Released, Precisely Positioned 3D Scene, Listening to "Moonlight Song" and Talking about Beethoven Images | Applications | Beethoven

Not only can you hear Beethoven talk freely in "Moonlight", but you can also achieve precise positioning in three-dimensional scenes, and complete scene analysis through the combination of images and sound. On June 16, at the AI Framework Ecological Summit, the Institute of Automation of the Chinese Academy of Sciences officially released the full mode large model of "Zidong Taichu". This model is the 2.0 version upgraded from the 1.0 version of the 100 billion parameter multimodal model "Zidong Taichu". On the basis of voice, image and text three modes, it adds video, sensor signal, 3D point cloud and other modal data, breaks through the key technologies such as multimodal correlation for cognitive enhancement, and has full modal understanding, generation and correlation capabilities. At the meeting, Xu Bo, the director of the Institute of Automation, presented for the first time in real time the "Zidong Taichu" full modal cognitive model in music understanding

Perseverance is a life experience. Lingling Middle School has weak muscles. Candidates complete the college entrance examination: no matter what difficulties they experience. High school | school | college entrance examination
Perseverance is a life experience. Lingling Middle School has weak muscles. Candidates complete the college entrance examination: no matter what difficulties they experience. High school | school | college entrance examination

"The college entrance examination is an experience in our lives. Looking back on the preparation for the entire senior year of high school, we cannot help but marvel at the preciousness of time. No matter what difficulties we have gone through, I believe that as long as we persist, it will become my lifelong wealth. Today, after completing the morning foreign language listening and speaking test of the college entrance examination, Xiao Song, a senior student of Lingling High School, came out of the examination center of East China University of Science and Technology Affiliated Middle School. The senior year graduate sitting in a wheelchair said," Although academic and life are not small tests for me, I have faced many difficulties in adversity and have never given up on my dream of taking the college entrance examination. "Xiao Song suffered from congenital muscular dystrophy since childhood and entered Lingling High School in high school." Later, the school provided him with classrooms on low floors and close to the toilet, making it easier for him to enter and exit, allowing him to face his academic life with more confidence. At school, I met many kind and enthusiastic people